Skip to main content
Home

Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE),  American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA). 

RSS icon

  • older patient with a doctor at their house

    Persistent mitral regurgitation after TAVR more common among women than men

    The study's authors emphasized that these data should be kept in mind when making treatment decisions for female patients with severe AS. 

  • Heart attack patients treated at for-profit hospitals more likely to be readmitted

    Readmission rates are getting lower over time among patients treated at nonprofit hospitals. At for-profit facilities, meanwhile, readmission rates have stayed relatively unchanged.

  • A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

    High-quality heart failure care is easy to find for many Americans—but care gaps remain

    The Heart Failure Society of America has released a new comprehensive look at HF clinics in the United States. The report includes more than 300 programs that serve approximately 626,000 patients.

  • obesity semaglutide tirzepatide GLP-1 drugs weight loss

    Semaglutide is improving the heart health of millions—but how? Experts are stumped

    “Our analyses could not fully ascribe the effects of semaglutide on cardiovascular disease to known risk factors with any certainty,” one researcher said after exploring years of data. "These results suggest that semaglutide should be considered as a cardiovascular disease reduction drug and not just as a weight loss drug." 

  • artificial intelligence AI heart cardiology

    AI uses routine CT images to evaluate cardiovascular risk

    Researchers have trained a new AI model to read routine medical images and deliver accurate cardiovascular age assessments.

older patient with a doctor at their house

Persistent mitral regurgitation after TAVR more common among women than men

The study's authors emphasized that these data should be kept in mind when making treatment decisions for female patients with severe AS. 

Heart attack patients treated at for-profit hospitals more likely to be readmitted

Readmission rates are getting lower over time among patients treated at nonprofit hospitals. At for-profit facilities, meanwhile, readmission rates have stayed relatively unchanged.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

High-quality heart failure care is easy to find for many Americans—but care gaps remain

The Heart Failure Society of America has released a new comprehensive look at HF clinics in the United States. The report includes more than 300 programs that serve approximately 626,000 patients.

obesity semaglutide tirzepatide GLP-1 drugs weight loss

Semaglutide is improving the heart health of millions—but how? Experts are stumped

“Our analyses could not fully ascribe the effects of semaglutide on cardiovascular disease to known risk factors with any certainty,” one researcher said after exploring years of data. "These results suggest that semaglutide should be considered as a cardiovascular disease reduction drug and not just as a weight loss drug." 

artificial intelligence AI heart cardiology

AI uses routine CT images to evaluate cardiovascular risk

Researchers have trained a new AI model to read routine medical images and deliver accurate cardiovascular age assessments.

Damodhar Suresh, MD, executive medical director of St. Elizabeth Healthcare Heart and Vascular Institute in Edgewood, Kentucky. He is also a volunteer current science chair for the International committee for the American Heart Association (AHA), explains how the AHA is helping cardiologists from numerous countries put in place systems of care to standardize how heart attack patients are treated.

American Heart Association helping countries all over the world improve care

The AHA has developed systems of care that can help developing countries improve their treatment strategies for both heart attack and stroke.

Jennifer S. Lawton, MD

Veteran surgeon to be honored by American Heart Association for groundbreaking research

Jennifer S. Lawton, MD, is known for her research on how to protect the heart and brain during cardiac surgeries. She has also spent her career mentoring trainees and serving in a variety of leadership positions. 

Sanjiv Narayan, MBChB, MD, MSc, FRCP, an American Heart Association volunteer, Director of the Electrophysiology Research and Atrial Fibrillation Program, and Co-Founder of the Stanford Arrhythmia Center, at Stanford Medicine, spoke in sessions at the European Society of Cardiology (ESC) 2026 Congress about the use of artificial intelligence in AFib care, using smarter detection to enable better outcomes.

AI gaining ground in electrophysiology, but clinicians still run the show

Even as AI is used more and more in the field, cardiologists and other clinicians are at the heart of patient care. 

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page Next ›
    • Last page Last »
Displaying 1 - 8 of 1678
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme